Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.18 - $7.74 $15,160 - $28,072
-3,627 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.12 - $11.06 $15,386 - $23,900
-2,161 Reduced 37.34%
3,627 $29,000
Q3 2021

Nov 15, 2021

SELL
$10.25 - $15.21 $92,875 - $137,817
-9,061 Reduced 61.02%
5,788 $79,000
Q2 2021

Aug 16, 2021

BUY
$12.4 - $17.92 $94,612 - $136,729
7,630 Added 105.69%
14,849 $223,000
Q3 2020

Nov 17, 2020

BUY
$10.56 - $16.69 $23,094 - $36,501
2,187 Added 43.46%
7,219 $78,000
Q1 2020

May 13, 2020

SELL
$12.7 - $25.95 $317 - $648
-25 Reduced 0.49%
5,032 $80,000
Q4 2019

Feb 14, 2020

BUY
$12.61 - $28.48 $63,768 - $144,023
5,057 New
5,057 $128,000

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.